These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 28938615
1. Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification. Takase S, Kano S, Tada Y, Kawakita D, Shimura T, Hirai H, Tsukahara K, Shimizu A, Imanishi Y, Ozawa H, Okami K, Sato Y, Sato Y, Fushimi C, Okada T, Sato H, Otsuka K, Watanabe Y, Sakai A, Ebisumoto K, Togashi T, Ueki Y, Ota H, Hanazawa T, Chazono H, Osamura RY, Nagao T. Oncotarget; 2017 Aug 29; 8(35):59023-59035. PubMed ID: 28938615 [Abstract] [Full Text] [Related]
2. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications. Santana T, Pavel A, Martinek P, Steiner P, Grossmann P, Baněčková M, Skálová A. Hum Pathol; 2019 Nov 29; 93():37-47. PubMed ID: 31437521 [Abstract] [Full Text] [Related]
3. The clinicopathological significance of the adipophilin and fatty acid synthase expression in salivary duct carcinoma. Hirai H, Tada Y, Nakaguro M, Kawakita D, Sato Y, Shimura T, Tsukahara K, Kano S, Ozawa H, Okami K, Sato Y, Fushimi C, Shimizu A, Okamoto I, Takase S, Okada T, Sato H, Imanishi Y, Otsuka K, Watanabe Y, Sakai A, Ebisumoto K, Togashi T, Ueki Y, Ota H, Saigusa N, Takahashi H, Ando M, Urano M, Hanazawa T, Nagao T. Virchows Arch; 2020 Aug 29; 477(2):291-299. PubMed ID: 32103349 [Abstract] [Full Text] [Related]
8. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions. Bahrami A, Perez-Ordonez B, Dalton JD, Weinreb I. Histopathology; 2013 Aug 29; 63(2):250-62. PubMed ID: 23738717 [Abstract] [Full Text] [Related]
12. Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas. Shimura T, Tada Y, Hirai H, Kawakita D, Kano S, Tsukahara K, Shimizu A, Takase S, Imanishi Y, Ozawa H, Okami K, Sato Y, Sato Y, Fushimi C, Takahashi H, Okada T, Sato H, Otsuka K, Watanabe Y, Sakai A, Ebisumoto K, Togashi T, Ueki Y, Ota H, Ando M, Kohsaka S, Hanazawa T, Chazono H, Kadokura Y, Kobayashi H, Nagao T. Oncotarget; 2018 Jan 05; 9(2):1852-1867. PubMed ID: 29416736 [Abstract] [Full Text] [Related]
13. Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type. Hsieh MS, Lee YH, Jin YT, Kuo YJ. Virchows Arch; 2020 Oct 05; 477(4):581-592. PubMed ID: 32383006 [Abstract] [Full Text] [Related]
15. Frequent apocrine changes in pleomorphic adenoma with malignant transformation: a possible pre-malignant step in ductal carcinoma ex pleomorphic adenoma. Song JS, Kim Y, Lee YS, Choi SH, Nam SY, Kim SY, Cho KJ. J Pathol Transl Med; 2023 May 05; 57(3):158-165. PubMed ID: 37194149 [Abstract] [Full Text] [Related]
18. Salivary duct carcinoma with rhabdoid features: a salivary counterpart of pleomorphic lobular carcinoma of the breast. Kusafuka K, Kawasaki T, Maeda M, Yamanegi K, Baba S, Ito Y, Inagaki H, Nakajima T. Histopathology; 2017 Jan 05; 70(2):164-173. PubMed ID: 27079821 [Abstract] [Full Text] [Related]
19. Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers. Tsang JY, Ni YB, Chan SK, Shao MM, Law BK, Tan PH, Tse GM. Ann Surg Oncol; 2014 Jul 05; 21(7):2218-28. PubMed ID: 24639191 [Abstract] [Full Text] [Related]